When it comes to Yacov Geva, the check is always in the mail. Clinical tests have been completed for China NMPA. No way the company will delist from ASX. Prizma will be sold by Guthy-Renker next month. Covid testing will go thru the roof this quarter. We'll tell you everything soon in a conference call. The naked shorts are hurting the shareholders! How dare they! That's my job! There will be no dilution til SP = $6. And now -- allergy testing. HOW EXCITING. As the saying goes, the scumbag fraudster conman does not change its spots.
GMV Price at posting:
3.9¢ Sentiment: None Disclosure: Held
